News/ News/ R&D Takeda buys GammaDelta to boost cancer cell therapy credentials Phil Taylor cell therapy, GammaDelta Therapeutics, immuno-oncology, M&A, Oncology, R&D, Takeda 0 Comment Japanese drugmaker Takeda has said it will exercise its option to buy UK-based GammaDelta Therapeutics, a specialist in Share X Takeda buys GammaDelta to boost cancer cell therapy credentials https://pharmaphorum.com/news/takeda-buys-gammadelta-to-boost-cancer-cell-therapy-credentials/